Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab

Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab

TAFRO syndrome, a rare subtype of idiopathic multicentric Castleman disease, manifests as thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly. Thrombotic microangiopathy, including renal dysfunction, is frequently associated with this syndrome. TAFRO syndrome can be life threaten...

Full description

Bibliographic Details
Main Authors: Yuina Akagi, Takashi Kato, Yusuke Yamashita, Hiroki Hosoi, Shogo Murata, Shuto Yamamoto, Kenji Warigaya, Taisei Nakao, Shinichi Murata, Takashi Sonoki, Shinobu Tamura
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Medicina
Subjects:
TAFRO syndrome
thrombotic microangiopathy
cyclosporine A
rituximab
intracranial hemorrhage
Online Access:https://www.mdpi.com/1648-9144/57/9/971

Internet

https://www.mdpi.com/1648-9144/57/9/971

Similar Items